Lincoln Pharmaceuticals Ltd
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 |
|---|---|---|---|
| Revenue | 200.88 | 201.55 | 183.08 |
| Operating Expense | 167.66 | 149.85 | 162.42 |
| Net Profit | 20.43 | 36.23 | 11.63 |
| Net Profit Margin | 10.17% | 17.98% | 6.35% |
| Earning Per Share | 10.20 | 18.09 | 5.81 |
| EBIDTA | 34.07 | 45.72 | 24.26 |
| Effective Tax Rate | 28.42% | 10.35% | 42.01% |
Particulars
Sep 2026
Revenue200.88
Operating Expense167.66
Net Profit20.43
Net Profit Margin10.17
Earning Per Share10.20
EBIDTA34.07
Effective Tax Rate28.42
